The global Erectile Dysfunction market size was valued at US$ 6084 million in 2024 and is forecast to a readjusted size of USD 9721 million by 2031 with a CAGR of 6.9% during review period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.
The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.
Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.
The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.
In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).
In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.
From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.
Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.
This report is a detailed and comprehensive analysis for global Erectile Dysfunction market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Erectile Dysfunction market size and forecasts, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031
Global Erectile Dysfunction market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031
Global Erectile Dysfunction market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031
Global Erectile Dysfunction market shares of main players, shipments in revenue ($ Million), sales quantity (Million Pill), and ASP (USD/Pill), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Erectile Dysfunction
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Erectile Dysfunction market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Erectile Dysfunction market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sildenafil
Tadalafil
Others
Market segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Major players covered
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erectile Dysfunction product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction, with price, sales quantity, revenue, and global market share of Erectile Dysfunction from 2020 to 2025.
Chapter 3, the Erectile Dysfunction competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Erectile Dysfunction market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Erectile Dysfunction.
Chapter 14 and 15, to describe Erectile Dysfunction sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Erectile Dysfunction Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Sildenafil
1.3.3 Tadalafil
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Erectile Dysfunction Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital Pharmacies
1.4.3 Private Clinics
1.4.4 Retail Pharmacies
1.4.5 E-Commerce (B2B)
1.4.6 E-Commerce (B2C)
1.5 Global Erectile Dysfunction Market Size & Forecast
1.5.1 Global Erectile Dysfunction Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Erectile Dysfunction Sales Quantity (2020-2031)
1.5.3 Global Erectile Dysfunction Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Erectile Dysfunction Product and Services
2.1.4 Eli Lilly Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Eli Lilly Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Erectile Dysfunction Product and Services
2.2.4 Pfizer Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pfizer Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Erectile Dysfunction Product and Services
2.3.4 Bayer Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Bayer Recent Developments/Updates
2.4 BaiYunShan General Factory
2.4.1 BaiYunShan General Factory Details
2.4.2 BaiYunShan General Factory Major Business
2.4.3 BaiYunShan General Factory Erectile Dysfunction Product and Services
2.4.4 BaiYunShan General Factory Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BaiYunShan General Factory Recent Developments/Updates
2.5 S.K. Chemicals
2.5.1 S.K. Chemicals Details
2.5.2 S.K. Chemicals Major Business
2.5.3 S.K. Chemicals Erectile Dysfunction Product and Services
2.5.4 S.K. Chemicals Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 S.K. Chemicals Recent Developments/Updates
2.6 Teva Pharma
2.6.1 Teva Pharma Details
2.6.2 Teva Pharma Major Business
2.6.3 Teva Pharma Erectile Dysfunction Product and Services
2.6.4 Teva Pharma Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Teva Pharma Recent Developments/Updates
2.7 Dong-A ST
2.7.1 Dong-A ST Details
2.7.2 Dong-A ST Major Business
2.7.3 Dong-A ST Erectile Dysfunction Product and Services
2.7.4 Dong-A ST Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Dong-A ST Recent Developments/Updates
2.8 Petros Pharmaceuticals
2.8.1 Petros Pharmaceuticals Details
2.8.2 Petros Pharmaceuticals Major Business
2.8.3 Petros Pharmaceuticals Erectile Dysfunction Product and Services
2.8.4 Petros Pharmaceuticals Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Petros Pharmaceuticals Recent Developments/Updates
2.9 Seoul Pharma
2.9.1 Seoul Pharma Details
2.9.2 Seoul Pharma Major Business
2.9.3 Seoul Pharma Erectile Dysfunction Product and Services
2.9.4 Seoul Pharma Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Seoul Pharma Recent Developments/Updates
2.10 Yabang Pharmacy
2.10.1 Yabang Pharmacy Details
2.10.2 Yabang Pharmacy Major Business
2.10.3 Yabang Pharmacy Erectile Dysfunction Product and Services
2.10.4 Yabang Pharmacy Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Yabang Pharmacy Recent Developments/Updates
3 Competitive Environment: Erectile Dysfunction by Manufacturer
3.1 Global Erectile Dysfunction Sales Quantity by Manufacturer (2020-2025)
3.2 Global Erectile Dysfunction Revenue by Manufacturer (2020-2025)
3.3 Global Erectile Dysfunction Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Erectile Dysfunction by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Erectile Dysfunction Manufacturer Market Share in 2024
3.4.3 Top 6 Erectile Dysfunction Manufacturer Market Share in 2024
3.5 Erectile Dysfunction Market: Overall Company Footprint Analysis
3.5.1 Erectile Dysfunction Market: Region Footprint
3.5.2 Erectile Dysfunction Market: Company Product Type Footprint
3.5.3 Erectile Dysfunction Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Erectile Dysfunction Market Size by Region
4.1.1 Global Erectile Dysfunction Sales Quantity by Region (2020-2031)
4.1.2 Global Erectile Dysfunction Consumption Value by Region (2020-2031)
4.1.3 Global Erectile Dysfunction Average Price by Region (2020-2031)
4.2 North America Erectile Dysfunction Consumption Value (2020-2031)
4.3 Europe Erectile Dysfunction Consumption Value (2020-2031)
4.4 Asia-Pacific Erectile Dysfunction Consumption Value (2020-2031)
4.5 South America Erectile Dysfunction Consumption Value (2020-2031)
4.6 Middle East & Africa Erectile Dysfunction Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Erectile Dysfunction Sales Quantity by Type (2020-2031)
5.2 Global Erectile Dysfunction Consumption Value by Type (2020-2031)
5.3 Global Erectile Dysfunction Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Erectile Dysfunction Sales Quantity by Application (2020-2031)
6.2 Global Erectile Dysfunction Consumption Value by Application (2020-2031)
6.3 Global Erectile Dysfunction Average Price by Application (2020-2031)
7 North America
7.1 North America Erectile Dysfunction Sales Quantity by Type (2020-2031)
7.2 North America Erectile Dysfunction Sales Quantity by Application (2020-2031)
7.3 North America Erectile Dysfunction Market Size by Country
7.3.1 North America Erectile Dysfunction Sales Quantity by Country (2020-2031)
7.3.2 North America Erectile Dysfunction Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Erectile Dysfunction Sales Quantity by Type (2020-2031)
8.2 Europe Erectile Dysfunction Sales Quantity by Application (2020-2031)
8.3 Europe Erectile Dysfunction Market Size by Country
8.3.1 Europe Erectile Dysfunction Sales Quantity by Country (2020-2031)
8.3.2 Europe Erectile Dysfunction Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Erectile Dysfunction Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Erectile Dysfunction Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Erectile Dysfunction Market Size by Region
9.3.1 Asia-Pacific Erectile Dysfunction Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Erectile Dysfunction Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Erectile Dysfunction Sales Quantity by Type (2020-2031)
10.2 South America Erectile Dysfunction Sales Quantity by Application (2020-2031)
10.3 South America Erectile Dysfunction Market Size by Country
10.3.1 South America Erectile Dysfunction Sales Quantity by Country (2020-2031)
10.3.2 South America Erectile Dysfunction Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Erectile Dysfunction Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Erectile Dysfunction Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Erectile Dysfunction Market Size by Country
11.3.1 Middle East & Africa Erectile Dysfunction Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Erectile Dysfunction Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Erectile Dysfunction Market Drivers
12.2 Erectile Dysfunction Market Restraints
12.3 Erectile Dysfunction Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Erectile Dysfunction and Key Manufacturers
13.2 Manufacturing Costs Percentage of Erectile Dysfunction
13.3 Erectile Dysfunction Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Erectile Dysfunction Typical Distributors
14.3 Erectile Dysfunction Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
听
听
*If Applicable.
